The Story: “Clotting is always a concern in patients undergoing coronary artery bypass graft surgery,” Dr. Linton explained. “Therefore, prior to Mr. Elliott’s surgery, we administered heparin.”
On April 15, John Elliott, a veteran, presented at a Veterans Administration (VA) hospital for the treatment of neck pain.
“While Mr. Elliott was hospitalized, his pain spread to his chest,” Dr. Linton continued. “We performed cardiac catheterization, which revealed coronary artery disease. On that same day, we administered heparin to Mr. Elliott to prepare him for coronary artery bypass graft surgery, which we performed on April 18.”
Mr. Elliott received a continuous heparin drip for 1 week. During that time, his limbs grew cold and black with gangrene, which was caused by the development of heparin-induced thrombocytopenia (HIT).
From April 17 to June 4, Mr. Elliott was heavily sedated and unconscious. On May 13, surgeons amputated his right leg above the knee because it had become gangrenous. On May 20, both of Mr. Elliott’s hands were amputated, and
2 days later his left leg below the knee was amputated because of gangrene.
“I regained consciousness on June 4,” Mr. Elliott recalled. “To my horror, I discovered that I was a quadruple amputee.
“The physicians told me that I had developed a heparin-induced allergic reaction that caused the gangrene, leaving them no choice but to amputate.”
Mr. Elliott was discharged from the hospital on July 23.
Almost 2 years later, in June, Mr. Elliott consulted with an attorney, who requested the patient’s medical records from the hospital. The attorney reviewed the records but declined to accept Mr. Elliott’s case.
In December, 6 months later, Mr. Elliott retained a new attorney, who promptly filed a complaint against the VA hospital pursuant to the Federal Torts Claims Act (FTCA).
“The physicians treating Mr. Elliott negligently failed to diagnose and treat his HIT, which resulted in the amputation of his legs and hands,” Mr. Elliott’s medical malpractice complaint charged.
The VA hospital attorneys argued that even if the VA physicians had been negligent, Mr. Elliott’s suit was time-barred by the FTCA’s 2-year statute of limitations.
“The FTCA requires that malpractice claims against government-operated hospitals be brought within 2 years of the date the action accrues,” the attorneys representing the VA hospital argued. “Mr. Elliott’s malpractice claim accrued, at the latest, on July 23—the date he was discharged from the hospital.
“By July 23, Mr. Elliott knew that he had been injured and that he was a quadruple amputee,” the VA hospital’s attorneys continued. “The VA physicians also had told Mr. Elliott that the amputation was a result of an allergic reaction to the heparin that had been administered in the hospital.”
Mr. Elliott’s attorneys responded that the 2-year statute of limitations should be considered tolled (ie, suspended) until the time that the first attorney had obtained and reviewed the patient’s hospital records.
“The VA physicians never told me that if my HIT had been diagnosed in a timely fashion, it could have been treated and arrested with anticoagulants,” Mr. Elliott insisted.
“I was simply told that my injuries were caused by an unforeseeable allergic reaction to the heparin. My attorney was the first person to inform me that I lost my limbs because of medical malpractice.”
The Result: More facts are needed to determine when the 2-year statute of limitations began, ruled the United States Court of Appeals.
In a medical malpractice action brought pursuant to the FTCA, the statute of limitations is tolled until a patient possesses facts that would enable a reasonable person to discover the alleged malpractice.
Mr. Elliott has alleged that his injuries did not occur solely because of the heparin-induced reaction, which could have been halted, but because the VA physicians failed to diagnose and treat his allergic reaction. Therefore, in this case, the issue of accrual depends on when Mr. Elliott discovered, or through the exercise of reasonable diligence should have discovered, that the failure of his physicians to diagnose and treat the allergic reaction led to his deteriorating condition.
Specifically, the court needs additional facts to determine when Mr. Elliott learned, or should have learned, that the VA physicians could have treated him with anticoagulants that would have arrested the HIT and saved his limbs, but failed to do so.
(CaseLawStoriesTM 0406001)(263 F.3d 272)
Comment: Patients do not have an unlimited amount of time in which to sue for medical malpractice. A patient’s right to sue is restricted by “statutes of limitations,” which generally range from 2 to 3 years. Each state, as well as the United States government, has its own statute of limitations governing malpractice suits.
In many states, the statute of limitations begins to run at the time of a physician’s alleged malpractice, regardless of when a patient discovers, or reasonably should have discovered, the alleged negligence.
In other states, as well as in medical malpractice claims brought against the United States government, the statute of limitations does not begin to run until a patient discovers, or in the exercise of reasonable diligence should have discovered, the malpractice.
In jurisdictions that apply a “discovery rule” to their statutes of limitations, there is a great deal of litigation regarding what constitutes “reasonable diligence” in discovering that medical malpractice was the cause of a patient’s injury.
PEER REVIEW
HIT COMMENTARY
Louis M. Guzzi, MD, FCCM
Attending and Section Chief, Critical Care Medicine
JLR Medical Group
Associate Professor of Anesthesia, Florida State University
Florida Hospital, Orlando, Florida
As increasing numbers of individuals have complicated vascular, cardiac, and invasive procedures performed, it is estimated that 12 million patients receive approximately 1 trillion units of heparin each year. As the practice of medicine becomes more and more complex, practitioners can be expected to be confronted with the possibility of providing heparin therapy to a patient who may have had prior exposure and may have experienced the near catastrophic and paradoxical response of unhindered coagulation.
The recognition of HIT revolves around vigilance, identification of platelet trends, and clinical suspicion. Any member of a patient’s health care team should be able to recognize HIT. The importance of identifying the disorder lies in making the correct diagnosis and then responding to those cases that require anticoagulation with appropriate therapy.
The triad of HIT identification includes a >30% decrease in platelet count from baseline, the onset of unexplained new thromboembolism, and the extension of thrombus on therapy or acute thrombus following prior exposure to heparin products. The essence of therapy is the immediate discontinuation of heparin products, the initiation of alternative anticoagulation therapy with a direct thrombin inhibitor (DTI), and, most importantly, for treatment not to be delayed while awaiting confirmation of laboratory results.
Given our current understanding of HIT as a disease process, the physician should be expected not only to be able to recognize HIT, but also to initiate therapy quickly. It would be reasonable to expect that in high-risk individuals who are required to receive acute anticoagulation therapy because of acute thrombosis, in the event of a low platelet count, a DTI may be initiated. This should be expected to be the standard of care, as the same end point is achieved and adequate inhibition of thrombosis is attained.
The recognition and treatment of the paradoxical process of thrombosis on active anticoagulation may become increasingly more common among medical practitioners. This may lead to significant litigation, as the end point of unchecked thrombosis might result in venous, arterial, or limb thrombosis, with serious consequences. The risk exists in any patient who previously has been exposed to a heparin-like product. Practitioners need to become more wary of using older types of high-risk therapy.
|